Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy

BACKGROUND: Prior studies have evaluated the use of various constituents of cannabis for their anti-seizure effects. Specifically, cannabidiol, a non-psychoactive component of cannabis, has been investigated for treatment-resistant epilepsy, but more information is needed particularly on its use in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheless, James W., Dlugos, Dennis, Miller, Ian, Oh, D. Alexander, Parikh, Neha, Phillips, Steven, Renfroe, J. Ben, Roberts, Colin M., Saeed, Isra, Sparagana, Steven P., Yu, Jin, Cilio, Maria Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534520/
https://www.ncbi.nlm.nih.gov/pubmed/31049885
http://dx.doi.org/10.1007/s40263-019-00624-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534520/
https://www.ncbi.nlm.nih.gov/pubmed/31049885
http://dx.doi.org/10.1007/s40263-019-00624-4

Ejemplares similares